SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004498
Filing Date
2018-05-09
Accepted
2018-05-09 16:38:44
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20180331x10q.htm 10-Q 1714195
2 EX-31.1 ptgx-20180331ex3111cd4e1.htm EX-31.1 12357
3 EX-31.2 ptgx-20180331ex312a99377.htm EX-31.2 13464
4 EX-32.1 ptgx-20180331ex3214a1725.htm EX-32.1 13736
  Complete submission text file 0001558370-18-004498.txt   6053055

Data Files

Seq Description Document Type Size
5 EX-101.INS ptgx-20180331.xml EX-101.INS 1286266
6 EX-101.SCH ptgx-20180331.xsd EX-101.SCH 44306
7 EX-101.CAL ptgx-20180331_cal.xml EX-101.CAL 42253
8 EX-101.DEF ptgx-20180331_def.xml EX-101.DEF 138084
9 EX-101.LAB ptgx-20180331_lab.xml EX-101.LAB 346439
10 EX-101.PRE ptgx-20180331_pre.xml EX-101.PRE 295093
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 18818909
SIC: 2834 Pharmaceutical Preparations